Clinical Trial Update: A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study update for CHF 1531 in asthma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CHF 1531

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2021-08-16